Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Annie Khamhoung"'
Autor:
Xuqing Zhang, Mengyao Luo, Shamael R. Dastagir, Mellissa Nixon, Annie Khamhoung, Andrea Schmidt, Albert Lee, Naren Subbiah, Douglas C. McLaughlin, Christopher L. Moore, Mary Gribble, Nicholas Bayhi, Viral Amin, Ryan Pepi, Sneha Pawar, Timothy J. Lyford, Vikram Soman, Jennifer Mellen, Christopher L. Carpenter, Laurence A. Turka, Thomas J. Wickham, Tiffany F. Chen
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
Red blood cells (RBCs) have unique properties that have been exploited for therapeutic uses. Here the authors engineer RBCs to co-express tumor associated antigens on MHC I, 4-1BBL and IL-12, generating artificial antigen presenting cells that can in
Externí odkaz:
https://doaj.org/article/81c7237bdaba401f8b24431f73e5d95a
Autor:
Finola Moore, Andres Alvarez, Alexia Barandiaran, Luke Barron, Eugene Choi, Krista Daniel, Charlotte Franco, Bashar Hamza, Jennifer Johnson, Annie Khamhoung, Marilyn Marques, Henry Moreno, Angela Nunez, Dominic Picarella Jared Sewell, Alex Storer, Meghan Walsh, Vipin Suri
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Douglas C. McLaughlin, Naren Subbiah, Timothy J. Lyford, Laurence A. Turka, Xuqing Zhang, Nicholas Bayhi, Shamael R. Dastagir, Mary Gribble, Ryan Pepi, Mengyao Luo, Viral Amin, Tiffany F. Chen, Christopher L. Moore, Annie Khamhoung, Christopher L. Carpenter, Mellissa J. Nixon, Albert Lee, Vikram Soman, Andrea Schmidt, Jennifer Mellen, Sneha Pawar, Thomas Joseph Wickham
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
Checkpoint inhibitors and T-cell therapies have highlighted the critical role of T cells in anti-cancer immunity. However, limitations associated with these treatments drive the need for alternative approaches. Here, we engineer red blood cells into
Autor:
Celeste Richardson, Finola Moore, Andres Alvarez, Alexia Barandiaran, Luke Barron, Eugene Choi, Tucker Ezell, Charlotte Franco, Bashar Hamza, Jennifer Johnson, Annie Khamhoung, Taeyoon Kyung, Marilyn Marques, Dominic Picarella, Jared Sewell, Alex Storer, Meghan Walsh, Vipin Suri
Publikováno v:
Cancer Research. 82:555-555
Despite the success of HER2 targeted therapies in HER2+ breast and gastric cancer, additional therapies are needed to address treatment-resistant metastatic disease. Adoptive immune cell therapy is a promising therapeutic modality given the remarkabl
Autor:
Lukasz Swiech, Jae Woong Chang, Simarjot Pabla, Celeste Richardson, Charlotte Franco, Beau R. Webber, Jennifer Johnson, Annie Khamhoung, Eugene Choi, Branden S. Moriarity, Vipin Suri, Meghan T. Walsh, Emily J. Pomeroy, Walker S. Lahr, Joshua Krueger
Publikováno v:
Blood. 138:1691-1691
Advances in cellular immunotherapy have led to multiple FDA approvals for autologous CAR-T cell therapies in acute lymphoblastic leukemia (ALL), non-Hodgkin's lymphomas (NHL), and multiple myeloma (MM). While effective, autologous CAR-T therapies are
Autor:
Douglas C. McLaughlin, Shamael R. Dastagir, Andrea Schmidt, Mellissa J. Nixon, Jennifer Mellen, Tom Wickham, Viral Amin, Albert Lee, Chris Carpenter, Xuqing Zhang, Mengyao Luo, Tiffany F. Chen, Annie Khamhoung, Christopher L. Moore
Publikováno v:
Cancer Research. 80:LB-082
Human papilloma virus (HPV)-infection is strongly associated with the risk of cancer, with the high-risk strain HPV16 accounting for ~80% of head and neck cancers. HPV16+ malignancies remain a critical area of high unmet need for new and innovative t